Pulling SEC filings + quote and writing the call…

Pulmonx Corp
Next earnings Jul 28, 2026 (after close) · consensus $-0.29 EPS, $22.8M rev
Last earnings -2.4% on 2026-04-29
Revenue grew 8.0% YoY; but unprofitable (net margin -59.7%).
Pulmonx Corp shows $90.5M in FY2025 revenue (+8.0% YoY), a -59.7% net margin, and -99.8% ROE.
Sources: SEC EDGAR (CIK 0001127537, latest 10-Q filed 2026-05-04) · as of 6/26/2026, 4:13:02 PM.
Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.
The risks, catalysts, 12-month price target and the cited SEC figures behind this rating — with Pro.
Unlock with Pro€15/mo · cancel anytime
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | $48.4M | $53.7M | $68.7M | $83.8M | $90.5M |
| Gross profit | $35.6M | $39.9M | $50.8M | $62.0M | $67.1M |
| Operating income | -$47.3M | -$58.6M | -$61.9M | -$57.7M | -$53.7M |
| Net income | -$48.7M | -$58.9M | -$60.8M | -$56.4M | -$54.0M |
| Diluted EPS | -$1.35 | -$1.59 | -$1.60 | -$1.44 | -$1.33 |
| Net margin | -100.5% | -109.8% | -88.6% | -67.3% | -59.7% |
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
1047 tracked peers · median
Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.
Last 90 days: 0 open-market buys · 8 sales
| 2026-06-05 | Burns Thomas William Director | Award | 40.0K | |
| 2026-06-05 | Ferrari Richard Director | Award | 40.0K | |
| 2026-06-05 | Florin Daniel P Director | Award | 40.0K | |
| 2026-06-05 | Melenikiotou Georgia Director | Award | 40.0K | |
| 2026-06-05 | Sullivan Tiffany Director | Award | 40.0K | |
| 2026-06-05 | Mead Dana G Jr. Director | Award | 40.0K | |
| 2026-06-01 | Radhakrishnan Srikanth Chief Science &Techn. Officer | Sell | 2.69K @ $1.54 | $4.14K |
| 2026-06-01 | Radhakrishnan Srikanth Chief Science &Techn. Officer | Sell | 2.15K @ $1.54 | $3.32K |
| 2026-06-01 | Radhakrishnan Srikanth Chief Science &Techn. Officer | Sell | 3.68K @ $1.54 | $5.67K |
| 2026-06-01 | Radhakrishnan Srikanth Chief Science &Techn. Officer | Sell | 5.97K @ $1.54 | $9.19K |
| 2026-06-01 | Lehman David Aaron GENERAL COUNSEL | Sell | 3.88K @ $1.54 | $5.97K |
| 2026-06-01 | Lehman David Aaron GENERAL COUNSEL | Sell | 2.26K @ $1.54 | $3.49K |